These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6150129

  • 1. Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.
    Nagao T, Ikeo T, Murata S, Sato M, Nakajima H.
    Jpn J Pharmacol; 1984 Aug; 35(4):415-23. PubMed ID: 6150129
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological analysis of positive chrono- and inotropic responses to denopamine (TA-064) in dog cross-circulated atrial and ventricular preparations.
    Akahane K, Furukawa Y, Karasawa Y, Ren LM, Chiba S.
    Jpn J Pharmacol; 1990 Jan; 52(1):69-79. PubMed ID: 1968521
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.
    Akahane K, Furukawa Y, Ogiwara Y, Haniuda M, Chiba S.
    Br J Pharmacol; 1989 Jul; 97(3):709-16. PubMed ID: 2474351
    [Abstract] [Full Text] [Related]

  • 4. Comparative positive inotropic effects of TA-064 (denopamine), a new cardiotonic agent, and isoproterenol and ouabain on guinea pig ventricular muscles.
    Sato T, Imanishi S, Arita M.
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):519-25. PubMed ID: 2478764
    [Abstract] [Full Text] [Related]

  • 5. Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat.
    Inamasu M, Totsuka T, Morita T, Takeyama S.
    Biochem Pharmacol; 1984 Jul 15; 33(14):2171-7. PubMed ID: 6147139
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T, Nagao T, Murata S, Yabana H, Sato M, Nakajima H.
    Arzneimittelforschung; 1986 Jul 15; 36(7):1063-8. PubMed ID: 3768073
    [Abstract] [Full Text] [Related]

  • 7. Positive chronotropic and inotropic responses to BRL 37344, a beta 3-adrenoceptor agonist in isolated, blood-perfused dog atria.
    Takayama S, Furukawa Y, Ren LM, Inoue Y, Sawaki S, Chiba S.
    Eur J Pharmacol; 1993 Feb 16; 231(3):315-21. PubMed ID: 8095462
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts.
    Silva CO, Monteiro-Filho WO, Duarte GP, Lahlou S.
    J Pharm Pharmacol; 2001 Feb 16; 53(2):233-42. PubMed ID: 11273021
    [Abstract] [Full Text] [Related]

  • 9. Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs.
    Ikeo T, Nagao T.
    Jpn J Pharmacol; 1985 Oct 16; 39(2):179-89. PubMed ID: 4087565
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide enhances the inotropic response to beta-adrenergic stimulation in the isolated guinea-pig heart.
    Prendergast BD, MacCarthy P, Wilson JF, Shah AM.
    Basic Res Cardiol; 1998 Aug 16; 93(4):276-84. PubMed ID: 9782370
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y, Sakuma I, Nakao Y, Kanno M.
    J Pharmacol Exp Ther; 1987 Sep 16; 242(3):1077-85. PubMed ID: 2888870
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of KM-13, a new, orally effective, cardiotonic sympathomimetic amine.
    Caldwell RW, Nash CB, Smulkowski M, Tuttle RR.
    J Cardiovasc Pharmacol; 1987 Mar 16; 9(3):375-84. PubMed ID: 2437405
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria.
    Lumley P, Broadley KJ, Levy GP.
    Cardiovasc Res; 1977 Jan 16; 11(1):17-25. PubMed ID: 12867
    [Abstract] [Full Text] [Related]

  • 14. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
    Brown L, Erdmann E.
    Cardiovasc Res; 1985 May 16; 19(5):288-98. PubMed ID: 3995524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S, Hosokawa T, Kojima M, Mori T, Yabuuchi Y.
    Arzneimittelforschung; 1984 May 16; 34(3A):342-6. PubMed ID: 6331464
    [Abstract] [Full Text] [Related]

  • 17. Inotropic and chronotropic effects of 4-(4'-n-butylaniline)-7,8- dimethoxy-5H-pyrimido[5,4-b]indole in guinea-pig atria.
    Castiella E, Frechilla D, Lasheras B, Cenarruzabeitia E, Martínez de Irujo JJ, Alberdi E, Santiago E, Monge A, Villanueva A, Martinez FJ.
    J Pharm Pharmacol; 1995 Jul 16; 47(7):601-7. PubMed ID: 8568629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
    Furukawa Y, Akahane K, Ogiwara Y, Haniuda M, Chiba S.
    Arch Int Pharmacodyn Ther; 1989 Jul 16; 300():159-73. PubMed ID: 2575887
    [Abstract] [Full Text] [Related]

  • 20. Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation.
    Schroth SC, Schotten U, Alkanoglu O, Reyle-Hahn MS, Hanrath P, Rossaint R.
    Anesthesiology; 2002 Feb 16; 96(2):422-7. PubMed ID: 11818777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.